SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD).
Iorio
Raffaele
R
Capone
Fioravante
F
Iannaccone
Elisabetta
E
Willison
Hugh John
HJ
Modoni
Anna
A
Tonali
Pietro Attilio
PA
Silvestri
Gabriella
G
D001259:Ataxia / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D001323:Autoantibodies / Q000032:analysis / Q000097:blood*; D018450:Disease Progression; D005260:Female; D005732:Gangliosides / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000276:immunology / Q000503:physiopathology; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007177:Inappropriate ADH Syndrome / Q000276:immunology* / Q000503:physiopathology; D008875:Middle Aged; D015835:Ocular Motility Disorders / Q000276:immunology / Q000503:physiopathology; D010525:Peripheral Nerves / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011129:Polyradiculoneuropathy / Q000150:complications / Q000276:immunology / Q000503:physiopathology; D012008:Recurrence; D012678:Sensation Disorders / Q000276:immunology / Q000503:physiopathology; D013577:Syndrome; D016896:Treatment Outcome
D001323:Autoantibodies; D005732:Gangliosides; D016756:Immunoglobulins, Intravenous; C056148:disialosyl Le(a)